WASHINGTON, Dec 29 (Reuters) – The US Food and Drug Administration failed to follow its own internal guidelines and practices during Biogen’s approval process. (BIIB.O) Aduhelm, the Alzheimer’s drug, was …
Tag:
REUTERS-LEGAL
-
-
Thousands of Zantac Lawsuits Dismissed Tuesday The decision bodes well for pending lawsuits: analysts GSK and Sanofi rally adds more than $20 billion to combined mkt cap LONDON, Dec 7 …